Skip to main content
. 2020 Aug 13;21(16):5819. doi: 10.3390/ijms21165819

Table 2.

Summary of the main molecular, cellular and behavioral alterations reported after perinatal stress exposure in rodents.

Stressor Stress Protocol Molecular/Cellular Behavior References
Assessment Age Assessment Age
Bad caregiving conditions Limited bedding (P1–P9) + 60 min immobilization (P10) or restraint (P20) ↑ spine density,
↑ spine number and ↑ excitability (pyramidal neurons BLA)
↑ BLA volume
P10, P20, P18 to P22 ↑ anxiety
↓ social contact
P60 to P78 [66]
Caregiver maltreatment (stressed dam) outside the home cage (30 min/day from P1 to P7) ↑ DNA methylation Bdnf exon IV (amygdala females)
↓ 5-hmC levels in (amygdala males)
P8, P30, P90 ↑anxiety P1 to P7 [67,68,69]
Insufficient bedding (from P8 to P12) ↑ amygdala neuronal activity P20, P45 ↓ social behavior, depressive-like symptoms P20, P45 [70]
Maternal separation 3 h/day from P2 to P12 in the home cage (dam removed) ↓ CB1-R binding sites in the amygdala (P40, P70), ↓ AEA content (P12, P14), ↑ 2-AG content (P12, P14) P2, P12, P14, P40, P70 [71,72]
30 min/day on P5, P16 and P21 outside the home cage (pups removed) ↑ BDNF protein levels in the amygdala adult ↓ anxiety Infant, Adult [73]
180 min/day from P2 to P14 outside the home cage (pups removed) ↑ BDNF expression in the CeA
↑ TrkB expression in the CeA
adult [74]
3 h/day from P5 to P10 outside the home cage (pups removed) ↑ DNA methyltransferases in the amygdala (P31)
↓ BDNF in the amygdala (P31, P86)
P31, P86 ↓ social interaction P30 to P31, P85 to P86 [75]
1 h/day from P1 to P21 outside the home cage (pups removed and placed individually) ↓ spine density in apical dendrites (pyramidal neurons MeA) P21 [76]
Drug administration (Δ9-THC) 5 mg/kg (oral in mothers) from G5 to weaning age (P24) ↓ density μ-opioid-R in posteromedial cortical amygdala (males)
↑ density μ-opioid-R in posteromedial cortical amygdala (females)
P70 [77]

Symbols and abbreviations: ↑ (increase), ↓ (decrease), G (gestational day), P (postnatal day), BLA (basolateral nuclei of the amygdala), LA (lateral nuclei of the amygdala), CB1-R (cannabinoid receptor 1), Bdnf (brain derived neurotrophic factor, gene), BDNF (brain derived neurotrophic factor, protein), 5hmC (5-Hydroxymethylcytosine), BLA (basolateral nucleus of the amygdala), CeA (central nucleus of the amygdala), TrKB (tropomyosin receptor kinase B), Δ9-THC (Δ9 tetrahydrocannabinol), AEA (anandamide), 2-AG (2-arachidonoyl glycerol), MeA (medial nucleus of the amygdala).